Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE - Delayed Quote USD

Solventum Corporation (SOLV)

67.62
+2.00
+(3.05%)
At close: May 2 at 4:00:02 PM EDT
67.62
0.00
(0.00%)
After hours: May 2 at 6:43:38 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Bryan C. Hanson CEO & Director 10.37M -- 1968
Mr. Wayde D. McMillan Chief Financial Officer 1.56M -- 1971
Ms. Amy Landucci Chief Information & Digital Officer 2.32M -- 1976
Ms. Tammy L. Gomez Chief Human Resources Officer 1.12M -- 1973
Mr. J. Christopher Barry Executive VP & Group President of Medical Surgical 1.76M -- 1972
Ms. Mary T. Wilcox Senior VP, Corporate Controller & Chief Accounting Officer -- -- 1965
Ms. Amy Wakeham Senior Vice President of Investor Relations & External Finance Communications -- -- --
Ms. Marcela A. Kirberger Chief Legal Affairs Officer & Corporate Secretary -- -- 1968
Ms. Kate Dobbs Chief Communications & Brand Officer -- -- --
Ms. Rachel H. Ellingson Chief Strategy & Corporate Development Officer -- -- 1970

Solventum Corporation

3M Center
Building 275-6W-20 2510 Conway Avenue East St. Paul
Maplewood, MN 55144-1000
United States
651 733 1110 https://www.solventum.com
Sector: 
Healthcare
Full Time Employees: 
22,000

Description

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.

Corporate Governance

Solventum Corporation’s ISS Governance QualityScore as of May 1, 2025 is 8. The pillar scores are Audit: 10; Board: 3; Shareholder Rights: 6; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 8, 2025 at 8:00 PM UTC

Solventum Corporation Earnings Date

Recent Events

May 2, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 21, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

February 28, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 27, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 11, 2024 at 12:00 AM UTC

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

November 26, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

November 19, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

November 15, 2024 at 12:00 AM UTC

S-4: Offering Registrations

November 8, 2024 at 12:00 AM UTC

IRANNOTICE: Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act

November 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.